{
    "clinical_study": {
        "@rank": "50145", 
        "arm_group": [
            {
                "arm_group_label": "Misoprostol", 
                "arm_group_type": "Experimental", 
                "description": "women with risk factors for uterine atony who underwent cesarean delivery were assigned randomly to 400 mcg misoprostol (2 tablets) (n=60)  placed in buccal space after umbilical cord clamping by anesthesiologist. The primary outcome variables were the need for additional uterotonic agents, estimated blood loss and uterine atony."
            }, 
            {
                "arm_group_label": "Folic Acid", 
                "arm_group_type": "Placebo Comparator", 
                "description": "women with risk factors for uterine atony who underwent cesarean delivery were assigned randomly to  10 mg Folic acid (2 tablets) (n=60) placed in buccal space after umbilical cord clamping by anesthesiologist. The primary outcome variables were the need for additional uterotonic agents, estimated blood loss and uterine atony."
            }
        ], 
        "brief_summary": {
            "textblock": "Objective: to demonstrate that buccal misoprostol administration during cesarean delivery in\n      women with risk factors for uterine atony decreases the need for additional  uterotonic\n      medications, uterine atony and postpartum hemorrhage.\n\n      Design: randomized, double-blinded, placebo-controlled trial."
        }, 
        "brief_title": "Buccal Misoprostol During Cesarean Section for Preventing Postpartum Hemorrhage", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "B1", 
                            "description": "women with risk factors for uterine atony who underwent cesarean delivery assigned randomly to 400 mcg misoprostol (2 tablets) (n=60) placed in buccal space after umbilical cord clamping by anesthesiologist. The primary outcome variables were the need for additional uterotonic agents, estimated blood loss and uterine atony.\nMisoprostol", 
                            "title": "Misoprostol"
                        }, 
                        {
                            "@group_id": "B2", 
                            "description": "women with risk factors for uterine atony who underwent cesarean delivery assigned randomly to 10 mg Folic acid (2 tablets) (n=60) placed in buccal space after umbilical cord clamping by anesthesiologist . The primary outcome variables were the need for additional uterotonic agents, estimated blood loss and uterine atony.\nPlacebo", 
                            "title": "Folic Acid"
                        }, 
                        {
                            "@group_id": "B3", 
                            "description": "Total of all reporting groups", 
                            "title": "Total"
                        }
                    ]
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "62"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "61"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "123"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@spread": "5.32", 
                                                "@value": "24.05"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@spread": "6.29", 
                                                "@value": "25.18"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@spread": "5.83", 
                                                "@value": "24.62"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "7"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "4"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "11"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "<=18 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "55"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "57"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "112"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Between 18 and 65 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "0"
                                                }
                                            ]
                                        }, 
                                        "sub_title": ">=65 years"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Age", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "62"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "61"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "123"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "0"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "62"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "61"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "123"
                                            }
                                        ]
                                    }, 
                                    "sub_title": "Mexico"
                                }
                            }, 
                            "param": "Number", 
                            "title": "Region of Enrollment", 
                            "units": "participants"
                        }
                    ]
                }
            }, 
            "certain_agreements": {
                "pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.", 
                "restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed."
            }, 
            "limitations_and_caveats": "Technical problems with blood loss measurement leading to blood transfusion before receiving hematocrit result.\nSmall number of patients fulfill inclusion criteria.", 
            "outcome_list": {
                "outcome": [
                    {
                        "analysis_list": {
                            "analysis": {
                                "group_id_list": {
                                    "group_id": [
                                        "O1", 
                                        "O2"
                                    ]
                                }, 
                                "method": "Fisher Exact", 
                                "non_inferiority": "No", 
                                "p_value": "<0.01"
                            }
                        }, 
                        "description": "The surgeon requested additional uterotonic agents on the basis of the clinical findings during surgery (e.g. uterine atony or blood loss of at least 1000 mL) Additional oxytocin was considered additional oxytocic intervention for purposes of data analysis.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "women with risk factors for uterine atony who underwent cesarean delivery were assigned randomly to either 400 mcg misoprostol (n=60) or placebo (n=60) placed in buccal space after umbilical cord clamping. The primary outcome variables were the need for additional uterotonic agents, estimated blood loss and uterine atony.\nMisoprostol", 
                                    "title": "Misoprostol"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "women with risk factors for uterine atony who underwent cesarean delivery were assigned randomly to either  misoprostol (n=60) or 10 mg Folic acid (n=60) placed in buccal space after umbilical cord clamping. The primary outcome variables were the need for additional uterotonic agents, estimated blood loss and uterine atony.\nPlacebo", 
                                    "title": "Folic Acid"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "60"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "60"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "10"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "40"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "The surgeon requested additional uterotonic agents on the basis of the clinical findings during surgery (e.g. uterine atony or blood loss of at least 1000 mL) Additional oxytocin was considered additional oxytocic intervention for purposes of data analysis.", 
                                    "param": "Number", 
                                    "title": "Need for Additional Uterotonic Medications", 
                                    "units": "percentage of participants"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "24 hours", 
                        "title": "Need for Additional Uterotonic Medications", 
                        "type": "Primary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": {
                                "group_id_list": {
                                    "group_id": [
                                        "O1", 
                                        "O2"
                                    ]
                                }, 
                                "method": "Fisher Exact", 
                                "non_inferiority": "No", 
                                "p_value": "0.026"
                            }
                        }, 
                        "description": "Uterine atony is defined as failure of the uterus to contract adequately following delivery. Recognition of a soft, \u201cboggy\u201d uterus in the setting of excessive postpartum bleeding can alert the attendant to atony and should trigger a series of interventions aimed at achieving tonic sustained uterine contraction.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "women with risk factors for uterine atony who underwent cesarean delivery were assigned randomly to either 400 mcg misoprostol (n=60) or placebo (n=60) placed in buccal space after umbilical cord clamping. The primary outcome variables were the need for additional uterotonic agents, estimated blood loss and uterine atony.\nMisoprostol", 
                                    "title": "Misoprostol"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "women with risk factors for uterine atony who underwent cesarean delivery were assigned randomly to either  misoprostol (n=60) or 10 mg Folic acid (n=60) placed in buccal space after umbilical cord clamping. The primary outcome variables were the need for additional uterotonic agents, estimated blood loss and uterine atony.\nPlacebo", 
                                    "title": "Folic Acid"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "60"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "60"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "8.3"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "25"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Uterine atony is defined as failure of the uterus to contract adequately following delivery. Recognition of a soft, \u201cboggy\u201d uterus in the setting of excessive postpartum bleeding can alert the attendant to atony and should trigger a series of interventions aimed at achieving tonic sustained uterine contraction.", 
                                    "param": "Number", 
                                    "title": "Uterine Atony", 
                                    "units": "percentage of participants"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "24 hours", 
                        "title": "Uterine Atony", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": {
                                "group_id_list": {
                                    "group_id": [
                                        "O1", 
                                        "O2"
                                    ]
                                }, 
                                "method": "Fisher Exact", 
                                "non_inferiority": "No", 
                                "p_value": "0.058"
                            }
                        }, 
                        "description": "Defined as:\nEstimated blood loss \u22651000 mL after cesarean delivery. A substantial fall in the haematocrit e.g. 10% The requirement for a blood transfusion", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "women with risk factors for uterine atony who underwent cesarean delivery were assigned randomly to either 400 mcg misoprostol (n=60) or placebo (n=60) placed in buccal space after umbilical cord clamping. The primary outcome variables were the need for additional uterotonic agents, estimated blood loss and uterine atony.\nMisoprostol", 
                                    "title": "Misoprostol"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "women with risk factors for uterine atony who underwent cesarean delivery were assigned randomly to either  misoprostol (n=60) or 10 mg Folic acid (n=60) placed in buccal space after umbilical cord clamping. The primary outcome variables were the need for additional uterotonic agents, estimated blood loss and uterine atony.\nPlacebo", 
                                    "title": "Folic Acid"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "60"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "60"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "6.6"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "20"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Defined as:\nEstimated blood loss \u22651000 mL after cesarean delivery. A substantial fall in the haematocrit e.g. 10% The requirement for a blood transfusion", 
                                    "param": "Number", 
                                    "title": "Postpartum Hemorrhage", 
                                    "units": "percentage of patients"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "24 HOURS", 
                        "title": "Postpartum Hemorrhage", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": {
                                "group_id_list": {
                                    "group_id": [
                                        "O1", 
                                        "O2"
                                    ]
                                }, 
                                "method": "Kruskal-Wallis", 
                                "non_inferiority": "No", 
                                "p_value": "0.007"
                            }
                        }, 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "women with risk factors for uterine atony who underwent cesarean delivery were assigned randomly to either 400 mcg misoprostol (n=60) or placebo (n=60) placed in buccal space after umbilical cord clamping. The primary outcome variables were the need for additional uterotonic agents, estimated blood loss and uterine atony.\nMisoprostol", 
                                    "title": "Misoprostol"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "women with risk factors for uterine atony who underwent cesarean delivery were assigned randomly to either  misoprostol (n=60) or 10 mg Folic acid (n=60) placed in buccal space after umbilical cord clamping. The primary outcome variables were the need for additional uterotonic agents, estimated blood loss and uterine atony.\nPlacebo", 
                                    "title": "Folic Acid"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "60"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "60"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "149.91", 
                                                        "@value": "470"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "342.21", 
                                                        "@value": "653.33"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Median", 
                                    "title": "Blood Loss", 
                                    "units": "mL"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "24 hours", 
                        "title": "Blood Loss", 
                        "type": "Secondary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "P1", 
                            "description": "women with risk factors for uterine atony who underwent cesarean delivery were assigned randomly to either 400 mcg misoprostol (n=62) or placebo (n=61) placed in buccal space after umbilical cord clamping. The primary outcome variables were the need for additional uterotonic agents, estimated blood loss and uterine atony.\nMisoprostol", 
                            "title": "Misoprostol"
                        }, 
                        {
                            "@group_id": "P2", 
                            "description": "women with risk factors for uterine atony who underwent cesarean delivery were assigned randomly to either  misoprostol (n=60) or 10 mg Folic acid (n=60) placed in buccal space after umbilical cord clamping. The primary outcome variables were the need for additional uterotonic agents, estimated blood loss and uterine atony.\nPlacebo", 
                            "title": "Folic Acid"
                        }
                    ]
                }, 
                "period_list": {
                    "period": {
                        "drop_withdraw_reason_list": {
                            "drop_withdraw_reason": [
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "1", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "1", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "Protocol Violation"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "1", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "Uterine artery injury"
                                }
                            ]
                        }, 
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "62", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "61", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "60", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "60", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "2", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "1", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }
            }, 
            "point_of_contact": {
                "email": "flaviohernandezc@yahoo.com", 
                "name_or_title": "Dr. Flavio Hern\u00e1ndez Castro", 
                "organization": "Hospital Universitario Jos\u00e9 Eleuterio Gonz\u00e1lez, Universidad Aut\u00f3noma de Nuevo Le\u00f3n", 
                "phone": "8112776459"
            }
        }, 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "condition": "Postpartum Hemorrhage", 
        "condition_browse": {
            "mesh_term": [
                "Hemorrhage", 
                "Postpartum Hemorrhage", 
                "Uterine Inertia"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients and methods: 120 pregnant women with risk factors for uterine atony who underwent\n      cesarean delivery were assigned randomly to either 400 mcg misoprostol (n=60) or placebo\n      (n=60) placed in buccal space after umbilical cord clamping. The primary outcome variables\n      were the need for additional uterotonic agents, estimated blood loss and uterine atony."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Women who underwent delivery either by elective or emergent cesarean section at 24\n             week gestation or later with preoperative levels of hemoglobin and hematocrit\n             determined up to 72 hours prior to delivery. The patients must have at least one of\n             the risk factors for uterine atony listed below:\n\n               1. Fetal macrosomia (estimated fetal weight  \u2265 4 Kilos) diagnosed by clinical\n                  measurement (Johnson\u00b4s technique) or ultrasound measurement (Hadlock\u00b4s formula).\n\n               2. Polyhydramnios (defined as Phelan\u00b4s amniotic fluid index > 24 cm)\n\n               3. Twin or Multiple pregnancy.\n\n               4. Prolonged labour (prolonged active phase > 12 hours) or precipitate\n                  labour(cervical dilatation \u2265 10 cm/hour).\n\n               5. Magnesium sulphate or any other tocolytic agent therapy for \u2265 8 hours before\n                  cesarean section.\n\n               6. Intravenous oxytocin therapy for at least 4 hours before cesarean section.\n\n               7. Multiparous women (\u2265 3 prior abdominal or vaginal deliveries )\n\n               8. Clinical chorioamnionitis  was defined as maternal temperature of \u2265 38\u00b0C in\n                  addition to more than one of the following criteria: fetal tachycardia (> 160\n                  beats per minute), maternal tachycardia (>100 beats per minute, maternal\n                  leukocytosis (15,000 cells/mm3), uterine tenderness or foul smelling amniotic\n                  fluid.\n\n               9. Known myomatosis, uterine M\u00fcllerian malformations or those diagnosed by\n                  ultrasound.\n\n        Exclusion Criteria:\n\n          1. Misoprostol incorrect administration\n\n          2. Severe allergic, bleeding disorders (e.g., haemophilia); severe asthma or any other\n             absolute contraindication to misoprostol use.\n\n          3. Any bleeding occurred before delivery (abruptio placentae, placenta praevia) or\n             bleeding due to other causes different than uterine atony."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "123", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 16, 2012", 
        "firstreceived_results_date": "December 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01733329", 
            "org_study_id": "GI07-011"
        }, 
        "intervention": [
            {
                "arm_group_label": "Misoprostol", 
                "description": "At cord clamping 2 tablets (400 mcg) were placed in the patient\u00b4s buccal space by anesthesiologist.", 
                "intervention_name": "Misoprostol", 
                "intervention_type": "Drug", 
                "other_name": "Cytotec"
            }, 
            {
                "arm_group_label": "Folic Acid", 
                "description": "At cord clamping 2 tablets (10 mg) were placed in the patient\u00b4s buccal space by anesthesiologist.", 
                "intervention_name": "Folic Acid", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Folic acid", 
                    "Placebo"
                ]
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Folic Acid", 
                "Vitamin B Complex", 
                "Hematinics", 
                "Misoprostol"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Buccal Misoprostol", 
            "Uterine Atony", 
            "Postpartum Hemorrhage"
        ], 
        "lastchanged_date": "February 12, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Monterrey", 
                    "country": "Mexico", 
                    "state": "Nuevo Le\u00f3n", 
                    "zip": "64460"
                }, 
                "name": "Hospital Universitario Dr. Jos\u00e9 Eleuterio Gonz\u00e1lez"
            }
        }, 
        "location_countries": {
            "country": "Mexico"
        }, 
        "number_of_arms": "2", 
        "official_title": "Buccal Misoprostol During Cesarean Section for Preventing Postpartum Hemorrhage in Women With Risk Factors for Uterine Atony", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Mexico: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The surgeon requested additional uterotonic agents on the basis of the clinical findings during surgery (e.g. uterine atony or blood loss of at least 1000 mL) Additional oxytocin was considered additional oxytocic intervention for purposes of data analysis.", 
            "measure": "Need for Additional Uterotonic Medications", 
            "safety_issue": "No", 
            "time_frame": "24 hours"
        }, 
        "reference": {
            "PMID": "15902121", 
            "citation": "Hamm J, Russell Z, Botha T, Carlan SJ, Richichi K. Buccal misoprostol to prevent hemorrhage at cesarean delivery: a randomized study. Am J Obstet Gynecol. 2005 May;192(5):1404-6."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01733329"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hospital Universitario Dr. Jose E. Gonzalez", 
            "investigator_full_name": "Flavio Hern\u00e1ndez Castro", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Uterine atony is defined as failure of the uterus to contract adequately following delivery. Recognition of a soft, \"boggy\" uterus in the setting of excessive postpartum bleeding can alert the attendant to atony and should trigger a series of interventions aimed at achieving tonic sustained uterine contraction.", 
                "measure": "Uterine Atony", 
                "safety_issue": "No", 
                "time_frame": "24 hours"
            }, 
            {
                "description": "Defined as:\nEstimated blood loss \u22651000 mL after cesarean delivery. A substantial fall in the haematocrit e.g. 10% The requirement for a blood transfusion", 
                "measure": "Postpartum Hemorrhage", 
                "safety_issue": "No", 
                "time_frame": "24 HOURS"
            }, 
            {
                "measure": "Blood Loss", 
                "safety_issue": "No", 
                "time_frame": "24 hours"
            }
        ], 
        "source": "Hospital Universitario Dr. Jose E. Gonzalez", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hospital Universitario Dr. Jose E. Gonzalez", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2008", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}